Slim Chiha

Slim Chiha is a co-founder and CEO of PROSION Therapeutics, a position held since January 2019. Prior to this role, Slim Chiha served as a postdoctoral researcher on a BMBF-funded drug discovery project for cancer therapy from January 2018 to December 2019. In 2012, Slim Chiha worked as a research scientist at Bayer Pharmaceuticals. Slim Chiha earned a Doctorate in Natural Sciences (Dr. rer. nat.) in Organic Chemistry from the University of Cologne, completing this degree between 2014 and 2017, and also studied at the University of Oxford.